Harvard Bioscience Sees Q3 Sales $19.000M-$21.000M vs $21.75M Est
Benzinga Newsdesk 1 year ago
NewsGuidance
Harvard Bioscience (NASDAQ:HBIO) sees Q3 sales of $19.000 million-$21.000 million vs $21.75 million analyst estimate.
Harvard Bioscience (NASDAQ:HBIO) sees Q3 sales of $19.000 million-$21.000 million vs $21.75 million analyst estimate.